sur Evotec AG (NASDAQ:EVTCY)
Evotec SE Set to Announce 2023 Fiscal Year Results
Hamburg-based Evotec SE will release its financial results for the year 2023 on April 24, 2024. Recognized on the Frankfurt Stock Exchange with symbols EVT, MDAX, TecDAX, and on NASDAQ as EVO, the life science company continues to engage its stakeholders effectively. A conference call, conducted in English, is scheduled to discuss the details and updates of the company's performance.
The announcement outlined webcast and conference call details, indicating that those interested can participate directly or through a pre-register link provided for phone access. Presentation materials will be accessible during the call, ensuring participants can follow the proceedings comprehensively.
Evotec’s broad engagement is further exemplified by its collaborations across top pharmaceutical companies and various biotechnology firms. The company strategically positions itself in key therapeutic sectors like neurology, oncology, and infectious diseases, emphasizing its role in innovative healthcare solutions.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Evotec AG